Molecular diagnostics is a dynamic and
transformative area of diagnostics, leading to insights in research and
treatment in many disease states that are revolutionizing health care. Molecular
diagnostics detects and measures the presence of genetic material or proteins
associated with a specific health condition or disease, helping to uncover the
underlying mechanisms of disease and enabling clinicians to tailor care at an
individual level facilitating the practice of personalized medicine.
Request a
sample of this report @ http://www.orbisresearch.com/contacts/request-sample/15237
Molecular diagnostics today is routinely used
in hospitals, reference labs, and blood banks. In the latter, molecular tests
are used to screen donated blood products for infectious diseases like
hepatitis and HIV. In hospitals, testing is often performed to identify
pathogens in patients with infections. In fact, infectious diseases are one of
the strongest growing areas within the molecular diagnostics field. There is
also increasing demand for such technologies at the point of care.
The report “Global Molecular Diagnostics
Market” provides an in-depth analysis of the molecular diagnostics market along
with a detailed study of its various segments. The major trends, growth drivers
as well as issues being faced by the industry are being presented in this
report. The four major players in the industry, Roche Holding AG, Qiagen NV,
Abbott Laboratories and Novartis are being profiled.
The key factors driving the growth of the
molecular diagnostics industry are rising incidence of chronic and infectious
disease, rising awareness and acceptance of personalized medicine, expansion in
emerging countries, ageing population and technological developments. Some of
the noteworthy trend and developments of this industry are growth of next
generation sequencing and growth in point of care diagnostics. However, the
expansion of global molecular diagnostics industry is hindered by challenges in
genetic diagnostics and regulatory issues.
By combining SPSS Inc.’s data integration and
analysis capabilities with our relevant findings, we have predicted the future
growth of the industry. We employed various significant variables that have an
impact on this industry and created regression models with SPSS Base to
determine the future direction of the industry. Before deploying the regression
model, the relationship between several independent or predictor variables and
the dependent variable was analyzed using standard SPSS output, including
charts, tables and tests.
Purchase a copy of Molecular Diagnostics Market
visit @ http://www.orbisresearch.com/reports/index/global-molecular-diagnostics-market-report-2015-edition
Table Of
Content:
1. Diagnostics: An
Overview
1.1 In Vitro Diagnostics
1.2 Molecular Diagnostics
1.1 In Vitro Diagnostics
1.2 Molecular Diagnostics
2. Diagnostics
Market
2.1 Global In Vitro Diagnostics (IVD) Market
-Market Value
-Market Segmentation
2.2 Global Molecular Diagnostics Market
-Market Value
-Market Segmentation
2.2.1 Human Papilloma Virus (HPV)
-Global Market Value
-Global Market Volume
2.2.2 CT/NG
-Global Market Value
-Global Market Volume
2.2.3 Global Genetic Testing Market
-Global Market Value
2.1 Global In Vitro Diagnostics (IVD) Market
-Market Value
-Market Segmentation
2.2 Global Molecular Diagnostics Market
-Market Value
-Market Segmentation
2.2.1 Human Papilloma Virus (HPV)
-Global Market Value
-Global Market Volume
2.2.2 CT/NG
-Global Market Value
-Global Market Volume
2.2.3 Global Genetic Testing Market
-Global Market Value
3. Market
Dynamics
3.1 Industry Trends and Developments
3.1.1 Growth of Next Generation Sequencing (NGS)
3.1.2 Growth in Point-of-Care Diagnostics
3.1.3 Growth in Non-Invasive Prenatal Testing (NIPT)
3.2 Growth Drivers
3.2.1 Rising Incidence of Chronic and Infectious Diseases
3.2.2 Technological Developments
3.2.3 Rising Awareness and Acceptance of Personalized Medicine
3.2.4 Economic Growth
3.2.5 Expansion in Emerging Countries
3.2.6 Ageing Population Worldwide
3.2.7 Rising Healthcare Expenditure
3.3 Issues and Challenges
3.3.1 Challenges in Genetic Diagnostics
3.3.2 Regulatory Issues
3.1 Industry Trends and Developments
3.1.1 Growth of Next Generation Sequencing (NGS)
3.1.2 Growth in Point-of-Care Diagnostics
3.1.3 Growth in Non-Invasive Prenatal Testing (NIPT)
3.2 Growth Drivers
3.2.1 Rising Incidence of Chronic and Infectious Diseases
3.2.2 Technological Developments
3.2.3 Rising Awareness and Acceptance of Personalized Medicine
3.2.4 Economic Growth
3.2.5 Expansion in Emerging Countries
3.2.6 Ageing Population Worldwide
3.2.7 Rising Healthcare Expenditure
3.3 Issues and Challenges
3.3.1 Challenges in Genetic Diagnostics
3.3.2 Regulatory Issues
For any enquires before buying, connect
with us @ enquiry@orbisresearch.com
About Us:
Orbis Research (orbisresearch.com) is a
single point aid for all your market research requirements. We have vast
database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our
clients. We have complete information about our publishers and hence are sure
about the accuracy of the industries and verticals of their specialization.
This helps our clients to map their needs and we produce the perfect required
market research study for our clients.
Contact
Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone No.: +1 (214) 884-6817;
+912064101019
No comments:
Post a Comment